Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

2,679 public trials 155 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent

NCT01511198

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Vestavia Hills, Alabama, United States
  • Novo Nordisk Investigational Site Tucson, Arizona, United States
  • Novo Nordisk Investigational Site Carlisle, Arkansas, United States
  • Novo Nordisk Investigational Site Jonesboro, Arkansas, United States
View all 39 locations
View Trial Details
Completed

Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

NCT00154401

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Aalborg, Denmark
  • Novo Nordisk Investigational Site Århus C, Denmark
  • Novo Nordisk Investigational Site Copenhagen, Denmark
  • Novo Nordisk Investigational Site Hellerup, Denmark
View all 39 locations
View Trial Details
Completed

Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

NCT00333151

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Goodyear, Arizona, United States
  • Novo Nordisk Investigational Site Colton, California, United States
  • Novo Nordisk Investigational Site Concord, California, United States
  • Novo Nordisk Investigational Site Escondido, California, United States
View all 89 locations
View Trial Details
Completed

Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 Diabetes

NCT01511172

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Daw Park, South Australia, Australia
  • Novo Nordisk Investigational Site Adelaide, Australia
  • Novo Nordisk Investigational Site Ashford, Australia
  • Novo Nordisk Investigational Site Garran, Australia
View all 41 locations
View Trial Details

Related conditions